Quantum BioPharma Ltd. (QNTM) — Cash Flow-to-Debt Ratio
Quantum BioPharma Ltd. (QNTM) has a Cash Flow-to-Debt Ratio of -0.10x as of March 2026, meaning its operating cash flow of $-1.65 Million could theoretically repay 0% of its total liabilities ($16.40 Million) in one year. See Quantum BioPharma Ltd. (QNTM) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Quantum BioPharma Ltd. Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Quantum BioPharma Ltd. across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Quantum BioPharma Ltd..
Annual Cash Flow-to-Debt Ratio for Quantum BioPharma Ltd. (2015–2025)
Year-by-year debt coverage analysis for Quantum BioPharma Ltd.. Check Quantum BioPharma Ltd. (QNTM) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.39x | $-8.38 Million | $6.05 Million | ▼ -34.6% |
| 2024 | -1.03x | $-6.88 Million | $6.68 Million | ▲ +56.6% |
| 2023 | -2.37x | $-10.83 Million | $4.57 Million | ▲ +34.1% |
| 2022 | -3.60x | $-28.33 Million | $7.87 Million | ▼ -53.3% |
| 2021 | -2.35x | $-20.75 Million | $8.83 Million | ▲ +30.5% |
| 2020 | -3.38x | $-19.13 Million | $5.66 Million | ▼ -71.1% |
| 2019 | -1.98x | $-13.71 Million | $6.94 Million | ▲ +81.4% |
| 2018 | -10.60x | $-13.58 Million | $1.28 Million | ▼ -8857.2% |
| 2017 | -0.12x | $-119.18K | $1.01 Million | ▲ +73.3% |
| 2016 | -0.44x | $-27.24K | $61.43K | ▼ -42203.3% |
| 2015 | 0.00x | $-63.44 | $60.53K | — |